Company

About Hanmi

한미약품은 창조와 도전을 기치로 신약개발에 매진하는 R&D중심 제약기업입니다.

History

2014

  • NovHanmi new RFID reader, grand prize for national excellence patent award
  • Phase 1 clinical trial of HM95573,a next-generation targeted therapy for melanoma treatment
  • OctBeijing Hanmi, received 'Presidential Prize' at 2014 Korea well-respected corporate awards
  • Received 'Minister Prize of Health and Welfare' at Sharing Korea awards
  • SepDiabetes-obesity biologics, presented at EASD
  • AugLicense agreement with Luye pharma group for targeted anti-cancer dug 'Poziotinib' in China
  • Diabetes biologic, 'LAPS efpeglenatide', completed patient recruitment in phase IIb clinical trial
  • JulContract with Actavis for exporting a hyaluronic acid injection
  • Hanmi opened the official blog 'Saranghanmida'
  • Hanmi-Novartis, diabetes treatment 'Galvus' co-promotion
  • JunTriaxone, obtained market authorization in 4 EU countries
  • sup>LAPSInsulin, weekly diabetes drug, presented at ADA
  • Rheumatoid arthritis drug, HM71224, presented at EULAR
  • The 8th Hanmi mid-small hospital award, Seungwon Hong, Director of Daejeon Christian General Hosipital
  • Plant in Pyeongtaek awarded for joining PIC/S by Korea Food & Drug Administration
  • May Diabetes-obesity new drug (LAPS-GLP-1/GCG) enters into global phase 1
  • Apr Probiotics for kids in Beijing Hanmi, 'Mamiai' is registered as China Famous Trade Mark
  • Decided to build an extension of BioPlant in Pyeongtaek
  • Received 'fair trade corporation' award by Fair Trade Commission
  • Launched Fluterol, DPI type asthma treatment drug
  • Mar 4th shareholders meeting of Hanmi Pharmaceuticals / 41st shareholders meeting of Hanmi Science
  • License agreement with Access Pharmaceuticals for Korean commercialization of 'Mugard'
  • Feb Hanmi-MSD, mutual co-promotion agreement for the sales of 12 products
  • Succeeded in seasoned equity offering (1 million shares)
  • Jan Hit 100 billion won in research and development as the first listed pharmaceutical company
  • Only one in the pharmaceutical industry to receive CP certificate(BBB grade)